Finance

Beta
Lists
LXEO:NASDAQ
Lexeo Therapeutics Inc
4,75 USD
+1,06%
(+0,050) 1D
4,75 USD
-0,00% (-0,00010)
After hours
Closed: 26-июн., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LXEO...
Open
4,69 USD
High
4,92 USD
Low
4,66 USD
Mkt. cap
372,98 млн
Avg. vol.
853,95 миң
Volume
2,34 млн
52-wk high
10,99 USD
52-wk low
3,60 USD
EPS
-1,45 USD
Shares outstanding
78,52 млн
No. of employees
59
Open
4,69 USD
High
4,92 USD
Low
4,66 USD
Mkt. cap
372,98 млн
Avg. vol.
853,95 миң
Volume
2,34 млн
52-wk high
10,99 USD
52-wk low
3,60 USD
EPS
-1,45 USD
Shares outstanding
78,52 млн
No. of employees
59
News stories
From sources across the web
About Lexeo Therapeutics Inc
CEO-
Employees59
Founded2017
Headquarters-
Sector-
Websitelexeotx.com
Analyst ratings
Based on 6 analysts giving stock ratings to LXEO in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for LXEO in the last 3 months.
Highest
Current 4,75 USD
20,00 USD (+321,05%)
Average
17,00 USD (+257,89%)
Lowest
9,00 USD (+89,47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tessa Romero
J.P. Morgan
Buy
Maintained
9,00 USD
+89,5%
06/25/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
17,00 USD
+257,9%
05/12/2026
Luca Issi
RBC Capital
Buy
Maintained
20,00 USD
+321,1%
05/11/2026
Unknown Analyst
Stifel Nicolaus
Buy
Maintained
17,00 USD
+257,9%
05/12/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
17,00 USD
+257,9%
05/11/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
20,00 USD
+321,1%
03/31/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
19,00 USD
+300%
03/30/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
10,00 USD
+110,5%
01/13/2026
Christopher Raymond
Raymond James
Buy
Maintained
25,00 USD
+426,3%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
-
-
-
-
Cost of goods sold
14,72 млн
15,70 млн
16,21 млн
15,70 млн
Cost of revenue
14,72 млн
15,70 млн
16,21 млн
15,70 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,97 млн
5,95 млн
6,91 млн
6,63 млн
Operating expense
15,97 млн
5,95 млн
6,91 млн
6,63 млн
Total operating expenses
30,69 млн
21,65 млн
23,12 млн
22,33 млн
Operating income
-30,69 млн
-21,65 млн
-23,12 млн
-22,33 млн
Other non operating income
-14,00 миң
-9,00 миң
9,00 миң
-1,00 миң
EBT including unusual items
-26,10 млн
-20,28 млн
-20,92 млн
-20,20 млн
EBT excluding unusual items
-29,46 млн
-20,22 млн
-20,91 млн
-20,24 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26,10 млн
-20,28 млн
-20,92 млн
-20,20 млн
Net profit margin
-
-
-
-
Earnings per share
-0,68
-0,33
-0,27
-0,25
Interest and investment income
1,27 млн
1,46 млн
2,21 млн
2,11 млн
Interest expense
-25,00 миң
-22,00 миң
-20,00 миң
-17,00 миң
Net interest expenses
1,24 млн
1,43 млн
2,19 млн
2,10 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-30,55 млн
-21,50 млн
-22,96 млн
-22,18 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of LXEO
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer